HI HB218

Requires dispensing pharmacies to provide accessible prescription drug label information to individuals who have difficulty seeing or reading standard printed labels, either through electronic labels on containers or free prescription drug readers.

Mandates pharmacies make sustained, periodic, and reasonable efforts to inform the public that accessible prescription drug label information is available in alternate formats.

Requires pharmacies to follow best practices recommended by the United States Access Board for providing independent access to prescription drug label information.

Exempts sole proprietorship pharmacies with no more than two pharmacists if they request and receive Board approval, subject to annual review based on undue burden findings under the Americans with Disabilities Act.

Directs the Board of Pharmacy to adopt rules by December 31, 2024, establishing requirements for hospital pharmacies and medication manufacturers, and allowing license denial, revocation, suspension, or fines up to $1,000 per violation for non-compliance.